Skip to main content

Georgia Talcum Trial Ends In Mistrial

Georgia Talcum Trial Ends In Mistrial

Georgia Talcum Trial Ends In Mistrial

Introduction

On Tuesday, a Fulton County State Court jury failed to reach a verdict in a case involving Johnson & Johnson’s (J&J) talcum powder, which allegedly caused a woman to die of ovarian cancer in 2016. The trial, considered to be the first talcum powder trial in Georgia, ended in a mistrial after the jury was deadlocked 10 to 2  in favor of the plaintiff.

The lawsuit involves a victim who died in 2016 after a three-year battle with ovarian cancer. Her family stated that she used J&J’s talcum powder products in her genital area for around 15 years, which they claimed was the reason for her cancer. The trial began on September 12, where the plaintiffs' attorney asked the jury to award more than $700,000 in lost wages and $1.3 million in medical bills, plus noneconomic damages for the 20 years that the victim would have lived.

Talc defendants are currently facing nearly 14,000 talcum powder and shower-to-shower lawsuits, consolidated under multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation), in the District of New Jersey. The MDL is presided by Hon. Freda L. Wolfson, U.S.D.J., and Hon. Lois H. Goodman, U.S.M.J.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.